Cost approval request for HyQvia® CIDP maintenance treatment
The document is a cost approval request for HyQvia®, a human immunoglobulin therapy, to be submitted to the health insurance under Article 71a-d KVV. The request includes coverage for HyQvia® and associated infusion equipment.
Homecare Services for subcutaneous immunoglobulin therapy
The document details the support offered by various Homecare Services for patients treated by subcutaneous immunoglobulin therapy. It also provides contact information for different homecare providers throughout Switzerland, emphasizing their availability and communication channels.